Wayne Godfrey
11Patents
9h-index
5Co-inventors
65Inventor score
Filing activity: Feb 16, 1988 → Jul 8, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5821332A | Receptor on the surface of activated CD4.sup.+ T-cells: ACT-4 | Physics | 32 | Expired |
| US6277962A | Receptor on the surface of activated t-cells: act-4 | Physics | 26 | Expired |
| US6528623B2 | Antibodies that specifically bind ACT-4-L-h-1 ligand | Chemistry; Metallurgy | 20 | Expired |
| US7098184B2 | Method of treating rheumatoid arthritis and multiple sclerosis diseases of the human immune system | Chemistry; Metallurgy | 19 | Expired |
| US6528055B2 | Methods of administering antibodies that specifically bind ACT-4-L-h-1 ligand | Chemistry; Metallurgy | 16 | Expired |
| US7364733B2 | Antibody to receptor on the surface of activated T-cells: ACT-4 | Physics | 15 | Expired |
| US6242566A | Ligand (ACT-4-L) to a receptor on the surface of activated CD4+ T-cells | Chemistry; Metallurgy | 12 | Expired |
| US6156878A | Ligand (ACT-4-L) to a receptor on the surface of activated CD4.sup.+ T-cells | Chemistry; Metallurgy | 12 | Expired |
| US4805280A | Method of joining metals of different physical properties | Emerging Cross-Sectional Technologies | 10 | Expired |
| US7125670B2 | Ligand (ACT-4-L) to a receptor on the surface of activated CD4+T-cells | Chemistry; Metallurgy | 2 | Expired |
| US8084033B2 | Composition comprising a cell expressing an AC133 cell surface antigen and an antibody or antigen-binding fragment | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.